Motley Fool Press Release.
CRYSTAL LAKE, Ill., October 29, 2026--Aptar Increases Quarterly Dividend to $0.50 Per Share
Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced the strategic acquisition of PULMOTREE, a Munich, Germany- based life science company specializing in pulmonary drug delivery systems for targeted delivery to the lungs. "The acquisition of PULMOTREE is an important step in expanding Aptar Pharma’ s...
CRYSTAL LAKE, Ill., September 14, 2026--Aptar and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
Aptar's ACT-101 is designed to intervene a step earlier than current CF modulators.
The custom pump has a 24/410 screw-on neck finish, with the actuator and collar enlarged to fit the broader bottle shape.
This is the newest page. Registered accounts read further back.